(Q37777290)

English

Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine

scientific article published on 02 August 2010

Statements

Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine (English)
Anthony Goncalves

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit